Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Frontiersin

Published November 18, 2026 · Updated November 19, 2026

Compassion and Psychedelics: A Scoping Review of Self-Compassion ... - Frontiers

Read the full story at Frontiersin

compassion, Mechanism, psychedelic -assisted therapy, psychedelics , Scoping review, self-compassion. Received. 10 September 2026. Accepted. 18 November.

Surfaced by this Google Alert

  • Psychedelics